Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.diabres.2020.108386 http://scihub22266oqcxt.onion/10.1016/j.diabres.2020.108386 32853685!7445120!32853685     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32853685&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Diabetes+Res+Clin+Pract 2020 ; 169 (?): 108386 Nephropedia Template TP {{tp|p=32853685|t=2020. The association of diabetes and the prognosis of COVID-19 patients: A retrospective study |pdf=|usr=}}{{32853685}} gab.com Text The association of diabetes and the prognosis of COVID-19 patients: A retrospective study JO: Diabetes Res Clin Pract http://www.kidney.de/pget.php?&tw=1&pmid=32853685 #FOAvip AIMS: This study evaluated the impact of previous glycemic control and in-hospital use of antidiabetic/antihypertensive drugs on the prognosis of COVID-19 patients with diabetes. METHODS: In this retrospective cohort study, consecutive inpatients with laboratory confirmed COVID-19 were enrolled from Tongji Hospital (Wuhan, China). Patients without diabetes were matched to those with diabetes based on age, sex, and comorbidities. All patients were followed up to a clinical endpoint (discharge, worsening including transferring to ICU or immediate death). Data and outcomes were extracted from medical records and analyzed. RESULTS: 64 patients with pre-existing diabetes were included in this study, with 128 matched patients without diabetes included as a control group. Patients with diabetes had a higher rate of worsening (18.8% versus 7.8%, p = 0.025). Multivariable regression showed increased odds of worsening associated with previous glycemic control reflected by HbA1c (odds ratio 3.29, 95% CI 1.19-9.13, p = 0.022) and receiver-operating characteristics (ROC) curve identified HbA1c of 8.6% (70 mmol/mol) as the optimal cut-off value. Univariate analysis demonstrated the in-hospital use of antidiabetic/antihypertensive drugs were not associated with a higher risk of worsening. CONCLUSIONS: COVID-19 patients with diabetes had a higher risk of worsening, especially those with poorly-controlled HbA1c, with an optimal cut-off value of 8.6%. The in-hospital use of antidiabetic/antihypertensive drugs were not associated with increased odds of worsening in patients with diabetes. Twit Text FOAVip The association of diabetes and the prognosis of COVID-19 patients: A retrospective study ????Diabetes Res Clin Pract http://www.kidney.de/pget.php?&tw=1&pmid=32853685 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32853685 #FOAvip English Wikipedia <ref>{{Cite pmid|32853685}}</ref> The association of diabetes and the prognosis of COVID-19 patients: A retrospective study #MMPMID32853685 Liu Z; Bai X; Han X; Jiang W; Qiu L; Chen S; Yu X Diabetes Res Clin Pract 2020[Nov]; 169 (?): 108386 PMID32853685show ga AIMS: This study evaluated the impact of previous glycemic control and in-hospital use of antidiabetic/antihypertensive drugs on the prognosis of COVID-19 patients with diabetes. METHODS: In this retrospective cohort study, consecutive inpatients with laboratory confirmed COVID-19 were enrolled from Tongji Hospital (Wuhan, China). Patients without diabetes were matched to those with diabetes based on age, sex, and comorbidities. All patients were followed up to a clinical endpoint (discharge, worsening including transferring to ICU or immediate death). Data and outcomes were extracted from medical records and analyzed. RESULTS: 64 patients with pre-existing diabetes were included in this study, with 128 matched patients without diabetes included as a control group. Patients with diabetes had a higher rate of worsening (18.8% versus 7.8%, p = 0.025). Multivariable regression showed increased odds of worsening associated with previous glycemic control reflected by HbA1c (odds ratio 3.29, 95% CI 1.19-9.13, p = 0.022) and receiver-operating characteristics (ROC) curve identified HbA1c of 8.6% (70 mmol/mol) as the optimal cut-off value. Univariate analysis demonstrated the in-hospital use of antidiabetic/antihypertensive drugs were not associated with a higher risk of worsening. CONCLUSIONS: COVID-19 patients with diabetes had a higher risk of worsening, especially those with poorly-controlled HbA1c, with an optimal cut-off value of 8.6%. The in-hospital use of antidiabetic/antihypertensive drugs were not associated with increased odds of worsening in patients with diabetes. |Aged[MESH] |Antihypertensive Agents/*therapeutic use[MESH] |COVID-19/*complications/transmission/virology[MESH] |China/epidemiology[MESH] |Comorbidity[MESH] |Diabetes Mellitus/drug therapy/*epidemiology/virology[MESH] |Female[MESH] |Glycemic Index[MESH] |Humans[MESH] |Hypoglycemic Agents/*therapeutic use[MESH] |Male[MESH] |Middle Aged[MESH] |Patient Discharge[MESH] |Prognosis[MESH] |ROC Curve[MESH] |Retrospective Studies[MESH] |Risk Factors[MESH]The association of diabetes and the prognosis of COVID-19 patients: A (epmc).pdf DeepDyve Pubget Overpricing